Epigenomics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 136,228 | 3.19% |
Private Companies | 316,169 | 7.41% |
Individual Insiders | 337,229 | 7.9% |
Institutions | 435,693 | 10.2% |
VC/PE Firms | 698,899 | 16.4% |
General Public | 2,342,211 | 54.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
698,899 | €426.3k | -39.8% | 0.19% | |||
316,169 | €192.9k | 101% | no data | |||
228,273 | €139.2k | 0.07% | 12.63% | |||
208,203 | €127.0k | 0% | no data | |||
207,338 | €126.5k | 0% | 0.12% | |||
136,228 | €83.1k | 0% | no data | |||
106,023 | €64.7k | 0% | no data | |||
23,003 | €14.0k | 0% | no data | |||
82 | €50.0 | 0% | no data |